(Press-News.org) Extended follow-up of the two Women's Health Initiative hormone therapy trials does not support use of hormones for chronic disease prevention, although the treatment may be appropriate for menopausal symptom management in some women, according to a study in the October 2 issue of JAMA.
The hormone therapy trials of the Women's Health Initiative (WHI) were stopped after investigators found that the health risks outweighed the benefits. Menopausal hormone therapy continues in clinical use, but questions remain regarding its risks and benefits over the long-term for chronic disease prevention, according to background information in the article.
JoAnn E. Manson, M.D., Dr.P.H., of Brigham and Women's Hospital, Boston, and colleagues provide a comprehensive, integrated overview of findings from the two WHI hormone therapy trials with extended post-intervention follow-up and stratification by age and other important variables. The study included 27,347 postmenopausal women, ages 50 through 79 years, who were enrolled at 40 U.S. centers in 1993. Women with an intact uterus received conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA) (n = 8,506) or placebo (n = 8,102). Women with prior hysterectomy received CEE alone (n = 5,310) or placebo (n = 5,429). The intervention lasted a median [midpoint] of 5.6 years in the CEE plus MPA trial, and 7.2 years in the CEE alone trial, with 6-8 additional years of follow-up until September 30, 2010.
The researchers found that overall, the risks of CEE+MPA during intervention outweighed the benefits. Risks were increased for coronary heart disease, breast cancer, stroke, pulmonary embolism, dementia (in women 65 years of age and older), gallbladder disease, and urinary incontinence. Benefits included decreased hip fractures, diabetes, and vasomotor symptoms. Most risks and benefits dissipated postintervention, although some elevation in breast cancer risk persisted during follow-up.
For CEE in women with prior hysterectomy, the benefits and risks during the intervention phase were more balanced, with increased risks of stroke and venous thrombosis, reduced risk of hip and total fractures, and a nonsignificant reduction in breast cancer. Post-intervention with CEE, a significant decrease in breast cancer emerged and most other outcomes were neutral. For CEE alone, younger women (age 50-59 years) had more favorable results for all-cause death and heart attack.
Neither regimen affected all-cause mortality.
"In summary, current WHI findings based on results from the intervention, postintervention, and cumulative posttrial stopping phases do not support the use of either estrogen-progestin or estrogen alone for chronic disease prevention," the authors write.
"Even though hormone therapy may be a reasonable option for management of moderate to severe menopausal symptoms among generally healthy women during early menopause, the risks associated with hormone therapy, in conjunction with the multiple testing limitations attending subgroup analyses, preclude a recommendation in support of CEE use for disease prevention even among younger women. Current findings also suggest caution when considering hormone therapy treatment in older age groups, even in the presence of persistent vasomotor symptoms, given the high risk of coronary heart disease and other outcomes associated with hormone therapy use in this setting."
(doi:10.l001/jama.2013.278040; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The Women's Health Initiative is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services. Wyeth-Ayerst donated the study drugs. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
There will also be a digital news release available for this study, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 3 p.m. CT Tuesday, October 1 at this link.
Editorial: The Women's Health Initiative - A Victory for Women and Their Health
"Twenty-two years following its inception, the WHI is a model for publicly funded rigorous, thorough, and objective clinical trials that have broadly affected human health. More than 160,000 women participated (many with great pride), more than 900 peer-reviewed reports from the WHI Publications and Presentations Committee have been published, the WHI data set is publically available, and scores of trainees have been mentored in fields from human biology to public health by participating in its analysis. The WHI has overturned medical dogma regarding the use of menopausal hormone therapy," writes Elizabeth G. Nabel, M.D., of Brigham and Women's Hospital, Boston, in an accompanying editorial.
"The WHI underscores the decisive importance of taxpayer-funded research conducted by the National Institutes of Health (NIH). Further reductions in the NIH budget virtually ensure that vitally important studies like the WHI will not be conducted, and hence, U.S. society will be poorly served. The fact that the public sector undertook this historic project (and that the researchers whose work is now reported have taken it to its next stage) has moved medical science forward by the most effective means of doing so—shattering prior dogma. For that, women and all patients whose health depends on sound science are grateful."
(doi:10.l001/jama.2013.278042; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
### END
Extended follow-up of hormone therapy trials does not support use for chronic disease prevention
2013-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Following bariatric surgery, use of opioids increases among chronic opioid users
2013-10-02
In a group of patients who took chronic opioids for noncancer pain and who underwent bariatric surgery, there was greater chronic use of opioids after surgery compared with before, findings that suggest the need for proactive management of chronic pain in these patients after surgery, according to a study in the October 2 issue of JAMA.
"Bariatric surgery is used to treat obesity, as well as its comorbid conditions such as cardiovascular and metabolic diseases and chronic pain. Bariatric surgery-related weight loss is associated with improvements in osteoarthritis-associated ...
Study finds increase in survival following bystander CPR for out-of-hospital cardiac arrest
2013-10-02
In Denmark between 2001 and 2010 there was an increase in bystander cardiopulmonary resuscitation (CPR) that was associated with an increase in survival following out-of-hospital cardiac arrest, according to a study in the October 2 issue of JAMA.
Out-of-hospital cardiac arrest affects approximately 300,000 individuals in North America annually. "Despite efforts to improve prognosis, survival remains low, with aggregated survival-to-discharge rates less than 8 percent. In many cases, time from recognition of cardiac arrest to the arrival of emergency medical services ...
Exercise 'potentially as effective' as many drugs for common diseases
2013-10-02
The researchers argue that more trials comparing the effectiveness of exercise and drugs are urgently needed to help doctors and patients make the best treatment decisions. In the meantime, they say exercise "should be considered as a viable alternative to, or alongside, drug therapy."
Physical activity has well documented health benefits, yet in the UK, only 14% of adults exercise regularly, with roughly one third of adults in England meeting recommended levels of physical activity. In contrast, prescription drug rates continue to skyrocket, sharply rising to an average ...
Low and high body mass index linked to increased risk of heart disease among east Asians
2013-10-02
The findings stress the important role of higher BMI in the increasing rates of death from cardiovascular disease in Asia, which could be managed by policy and prevention strategies, say the authors.
Cardiovascular disease (CVD) is the leading cause of death globally and is predicted to steadily increase over the next few decades. Many Asian populations that used to be physically active with a low BMI now have some of the world's highest rates of obesity.
Studies of BMI and CVD risk have generally been conducted in Europe and North America and no data is available ...
How ants investigate the housing market when searching for their ideal home
2013-10-02
Colonies of rock ants (Temnothorax albipennis) need to find ideal homes for the safety and productivity of the queen mother and all of her offspring. They are regularly confronted with the dilemma of whether to move to a better property or remain in their current one, but unlike humans who are susceptible to housing bubbles, ants seem to invest in their housing market in ways that are consistent and rational.
PhD student Carolina Doran and Professor Nigel R. Franks of Bristol's School of Biological Sciences showed experimentally that in order to be ahead of the game, ...
Mom's weight gain during pregnancy tied to childhood obesity
2013-10-02
Boston, MA - A study of 41,133 mothers and their children in Arkansas has shown that high pregnancy weight gain increases the risk of obesity in those children through age 12. The findings, published Oct. 1 in PLoS Medicine, suggest pregnancy may be an especially important time to prevent obesity in the next generation.
"From the public health perspective, excessive weight gain during pregnancy may have a potentially significant influence on propagation of the obesity epidemic," says the study's senior author David S. Ludwig, MD, PhD, director of the New Balance Foundation ...
Decoding sound's source: Mass. Eye and Ear researchers unravel part of the mystery
2013-10-02
BOSTON (Oct. 1, 2013) — As Baby Boomers age, many experience difficulty in hearing and understanding conversations in noisy environments such as restaurants. People who are hearing-impaired and who wear hearing aids or cochlear implants are even more severely impacted. Researchers know that the ability to locate the source of a sound with ease is vital to hear well in these types of situations, but much more information is needed to understand how hearing works to be able to design devices that work better in noisy environment.
Researchers from the Eaton-Peabody Laboratories ...
Study led by NYU Langone researchers finds the association between a high body mass index and the risk of death due to cardiovascular disease is stronger among east Asians than south Asians
2013-10-02
(New York City, October 1, 2013)- A study led by researchers at NYU Langone Medical Center and Fred Hutchinson Cancer Research Center has found that the association between body fat and mortality due to cardiovascular disease differs between south and east Asians, a finding that has important implications for global health recommendations. Cardiovascular disease, a condition in which arteries thicken and restrict blood flow, kills more than 17 million people annually, making it the leading cause of death worldwide.
In an analysis published today in the British Medical ...
Less can be more when removing lymph nodes during breast cancer surgery
2013-10-02
DALLAS – Oct. 1, 2013 – A conservative approach to removing lymph nodes is associated with less harm for breast cancer patients and often yields the same results as more radical procedures, researchers at UT Southwestern Medical Center have found.
In the Oct. 2 edition of the Journal of the American Medical Association, lead author
Dr. Roshni Rao, associate professor of surgery at UT Southwestern, and other investigators from the Harold C. Simmons Cancer Center reviewed studies on patient outcomes of women who had received various forms of surgical treatment, ranging ...
New fossils push the origin of flowering plants back by 100 million years to the early Triassic
2013-10-02
Flowering plants evolved from extinct plants related to conifers, ginkgos, cycads, and seed ferns. The oldest known fossils from flowering plants are pollen grains. These are small, robust and numerous and therefore fossilize more easily than leaves and flowers.
An uninterrupted sequence of fossilized pollen from flowers begins in the Early Cretaceous, approximately 140 million years ago, and it is generally assumed that flowering plants first evolved around that time. But the present study documents flowering plant-like pollen that is 100 million years older, implying ...